We are live on
!
Find out more
TB
Terril Brothers Portfolio holdings
AUM
$366M
1-Year Est. Return
29.25%
This Fund
S&P 500
This Quarter
Est. Return
+0.78%
1 Year Est. Return
+29.25%
3 Year Est. Return
+83.51%
5 Year Est. Return
+85.32%
10 Year Est. Return
+237.94%
AUM
$281M
AUM Growth
-$2.1M
(-0.74%)
Cap. Flow
-$3M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
74.06%
Holding
47
New
4
Increased
13
Reduced
16
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Plains GP Holdings
PAGP
|
+$7.34M |
| 2 |
Bausch Health
BHC
|
+$1.41M |
| 3 |
Ally Financial
ALLY
|
+$1.33M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$1.07M |
| 5 |
CEM
ClearBridge MLP and Midstream Fund Inc.
CEM
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$15.3M |
| 2 |
Apple
AAPL
|
+$398K |
| 3 |
Bank of America
BAC
|
+$232K |
| 4 |
MON
Monsanto Co
MON
|
+$191K |
| 5 |
FAX
abrdn Asia-Pacific Income Fund
FAX
|
+$186K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.98% |
| 2 | Healthcare | 16.95% |
| 3 | Technology | 13.36% |
| 4 | Materials | 11.41% |
| 5 | Energy | 9.72% |
Similar funds
CGC
FNBSF
MWPCG
AA
RAM
NECFA
LP
VA
Terril Brothers's Q2 2017 Portfolio in Review
As of Q2 2017, Terril Brothers held 47 positions worth $281M, down 0.74% from $283M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Terril Brothers's Q2 2017 filing shows 4 new, 13 increased, 16 reduced and 1 closed positions. Its largest new stake was Bausch Health: 117,350 shares worth $2.03M. The largest sale was Bioverativ Inc. Common Stock, an estimated $15.3M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.
- Terril Brothers's largest Q2 2017 buy was Bausch Health: 117,350 shares worth $2.03M.
- Terril Brothers added most to Plains GP Holdings in Q2 2017, an estimated $7.34M increase.
- Terril Brothers's biggest Q2 2017 reduction was Apple, cutting an estimated $398K.
- Terril Brothers fully exited Bioverativ Inc. Common Stock in Q2 2017, selling an estimated $15.3M.
- Terril Brothers's ten largest holdings make up 74% of its $281M portfolio in Q2 2017.
- Terril Brothers opened 4 new positions and closed 1 in Q2 2017.
- Terril Brothers's portfolio value fell 0.74% quarter-over-quarter to $281M.
Based on Terril Brothers's 13F filing for Q2 2017, filed 27 Jul 2017.